WYE-354
WYE-354 is an ATP-competitive mTOR inhibitor with an IC50 of 5 nM. WYE-354 also inhibits PI3Kα and PI3Kγ with IC50s of 1.89 μM and 7.37 μM, respectively. WYE-354 inhibits both mTORC1 and mTORC2. WYE-354 induces autophagy activation in vitro[3].
Product Specifications
CAS Number
1062169-56-5
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; Autophagy; mTOR
Type
Reference compound
Related Pathways
Apoptosis; Autophagy; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/WYE-354.html
Purity
98.03
Solubility
DMSO : 6.67 mg/mL (ultrasonic)
Smiles
COC(NC1=CC=C(C=C1)C2=NC3=C(C(N4CCOCC4)=N2)C=NN3C5CCN(CC5)C(OC)=O)=O
Molecular Formula
C24H29N7O5
Molecular Weight
495.53
Precautions
H302, H315, H319, H335
References & Citations
[1]Yu K et al. Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin. Cancer Res. 2009 Aug 1;69 (15) :6232-40.|[2]Weber H, et al. Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice. Oncotarget. 2015 Oct 13;6 (31) :31877-88.|[3]Lijun Wang, et al. Autophagy inhibition sensitizes WYE-354-induced anti-colon cancer activity in vitro and in vivo. Tumour Biol. 2016 Sep;37 (9) :11743-11752.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
MTOR; mTORC1; mTORC2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040837-100 1x 100 µL
Ep-CAM / CD326 (EGP40/837), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LC401656 20 µg
Pancreatic Lipase Related Protein 2 (PNLIPRP2) (NM_005396) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC400472-100 1x 100 µL
CD45RB (PD7/26), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details